Tech Company Financing Transactions
Specific Biologics Funding Round
Specific Biologics secured a $35 million Series A investment round on 11/2/2026. Backers included Hatteras Venture Partners, adMare BioInnovations and Business Development Bank of Canada.
Transaction Overview
Company Name
Announced On
11/2/2026
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
661 University Avenue, West Towern 1300
Toronto, Ontario, M5G 0B7
CA
Toronto, Ontario, M5G 0B7
CA
Phone
Undisclosed
Website
Email Address
Overview
Specific Biologics develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brent Stead
Chief Operating Officer
Odisho Israel
Browse more venture capital transactions:
Prev: 11/2/2026: nPhase venture capital transaction
Next: 11/2/2026: CYTO venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs